Todd Pletcher, the Hall of Fame trainer who was handed a 10-day suspension a month ago by New York regulators for a positive for a regulated medication that was stayed on appeal, has three medication positives pending in Florida from races in the past seven months, according to records of the Florida Division of Pari-Mutuel Wagering. The cases, which were first reported in The Paulick Report and confirmed through a public records request by Daily Racing Form, deal with a Class 5 medication used to treat ulcers, a Class 4 regulated corticosteroid, and a so-called “stacking violation” in which two regulated anti-inflammatory medications appeared in the same horse. In all three cases, hearings have yet to be scheduled. Pletcher declined to comment on the cases Thursday afternoon. The positives are minor violations under Florida’s racing regulatory scheme, and each of the positives might draw no more than a fine when considered individually. However, Pletcher’s positive in New York from a Sept. 5 race last year and the three positives in Florida in less than a year’s time could trigger higher penalties under a system used by racing in which multiple violations draw higher penalties, including suspensions. :: Bet the Belmont Stakes with confidence! Join DRF Bets and get a $250 deposit match bonus, $10 free bet, and FREE DRF Formulator! Two of the Florida positives occurred in horses that raced the same day, Dec. 10, at Gulfstream Park in Florida last year. The other was the result of a race on Feb. 3 at Gulfstream. According to the records, Ari Gold tested positive for an excessive concentration of omeprazole sulfide, an ingredient in a widely used ulcer medication, after winning the Pulpit Stakes on Dec. 10. Later on the card, Ok Boomer tested positive for dexamethasone, one of several corticosteroids regulated in horse racing, after winning the sixth race, a maiden special weight. The third complaint was filed after Six Minus won the eighth race at Gulfstream on Feb. 3 and tested positive for both ketoprofen and phenylbutazone, two regulated anti-inflammatory medications. Threshold levels used to regulate the administration time and doses of the two medications are higher when only one of the medications appears in a horse’s system, and lower when two appear.  While split-sample testing confirmed the positives in the two horses who raced on Dec. 10, a split-sample result has not yet been returned on Six Minus, according to the records. In the Sept. 5 race in New York, Forte, who was named the champion 2-year-old colt of last year, tested positive for meloxicam, a regulated drug that is rarely used in racing but appears in human medications. Pletcher has claimed that the positive was the result of contamination and has appealed. :: Take your handicapping to the next level and play with FREE DRF Past Performances - Formulator or Classic.  Under new rules that went into effect in New York and other major racing jurisdictions on May 22, the concentration of meloxicam in Forte would not have triggered an adjudication, according to Lisa Lazarus, the chief executive officer of the Horseracing Integrity and Safety Authority. Pletcher also told Daily Racing Form last month that a horse he trains, Mind Control, tested positive for a regulated medication after winning the Sept. 24 Parx Dirt Mile. A hearing in that case is also pending. Pletcher said he could not identify the substance involved in that case. :: Want to learn more about handicapping and wagering? Check out DRF's Handicapping 101 and Wagering 101 pages.